BA
SBBP

BlackRock Advisors’s Strongbridge Biopharma plc. SBBP Stock Holding History

BlackRock Advisors’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$73K Sell
30,582
-1,473
-5% -$6.01K ﹤0.01% 3154
2016
Q3 		$167K Sell
32,055
-599
-2% -$2.7K ﹤0.01% 2779
2016
Q2 		$130K Sell
32,654
-649
-2% -$3.06K ﹤0.01% 2830
2016
Q1 		$152K Sell
33,303
-833
-2% -$3.75K ﹤0.01% 2698
2015
Q4 		$259K Buy
+34,136
New +$245K ﹤0.01% 2432

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $22.1B AUM 41.68% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 374.17% 1-Year Est. Return

BlackRock Advisors's SBBP Position: Q4 2016 in Review

BlackRock Advisors reduced its Strongbridge Biopharma plc. (SBBP) stake by 4.6% in Q4 2016, selling an estimated $6.01K and leaving 30,582 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #3154.

BlackRock Advisors first reported a position in SBBP in Q4 2015 and has held it in 5 quarters since. The position peaked at $259K in Q4 2015. 18 funds tracked by Wall St. Rank hold SBBP as of Q4 2016.

  • BlackRock Advisors held 30,582 shares of Strongbridge Biopharma plc. worth $73K as of Q4 2016.
  • BlackRock Advisors sold 1,473 Strongbridge Biopharma plc. shares in Q4 2016, an estimated $6.01K.
  • Strongbridge Biopharma plc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3154 holding.
  • BlackRock Advisors first reported a position in Strongbridge Biopharma plc. in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Advisors's Strongbridge Biopharma plc. position peaked at $259K in Q4 2015.
  • 18 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.